We are live on ! Find out more
JAFL

Jay A. Fishman Ltd Portfolio holdings

AUM $1.12B
1-Year Est. Return 32.75%
This Fund
S&P 500
This Quarter Est. Return
+12.95%
1 Year Est. Return
+32.75%
3 Year Est. Return
+106.85%
5 Year Est. Return
+144.56%
10 Year Est. Return
+606.28%
AUM
$783M
AUM Growth
+$72.2M
Cap. Flow
+$4.78M
Cap. Flow %
0.61%
Top 10 Hldgs %
67.26%
Holding
96
New
–
Increased
22
Reduced
33
Closed
3

Top Buys

Rank Stock Value
1
ZTS icon
Zoetis
ZTS
+$7.32M
2
LMT icon
Lockheed Martin
LMT
+$3.75M
3
COST icon
Costco
COST
+$3.16M
4
MSFT icon
Microsoft
MSFT
+$1.41M
5
AMZN icon
Amazon
AMZN
+$1.26M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$5.3M
2
SYK icon
Stryker
SYK
+$1.17M
3
PFE icon
Pfizer
PFE
+$1.12M
4
TWI icon
Titan International
TWI
+$1.1M
5
V icon
Visa
V
+$967K

Sector Composition

Rank Sector Weight
1 Technology 32.98%
2 Healthcare 14.89%
3 Financials 14.29%
4 Industrials 11.7%
5 Consumer Discretionary 10.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TYRA icon
76
Tyra Biosciences
TYRA
$1.85B
$354K 0.05%
22,000
– –
SPY icon
77
State Street SPDR S&P 500 ETF Trust
SPY
$781B
$350K 0.04%
855
– –
INTU icon
78
Intuit
INTU
$83.1B
$326K 0.04%
732
– –
TSM icon
79
TSMC
TSM
$2.07T
$313K 0.04%
3,367
– –
MSCI icon
80
MSCI
MSCI
$41.5B
$291K 0.04%
520
-25
-5% -$13.2K
EXR icon
81
Extra Space Storage
EXR
$31.3B
$285K 0.04%
1,750
– –
MAR icon
82
Marriott International
MAR
$101B
$282K 0.04%
1,700
– –
PG icon
83
Procter & Gamble
PG
$346B
$268K 0.03%
1,801
+26
+1% +$3.72K
EXP icon
84
Eagle Materials
EXP
$6.69B
$249K 0.03%
1,700
– –
RIVN icon
85
Rivian
RIVN
$23.9B
$249K 0.03%
16,072
+172
+1% +$2.9K
IEMG icon
86
iShares Core MSCI Emerging Markets ETF
IEMG
$150B
$237K 0.03%
4,850
-200
-4% -$9.81K
SHYF
87
DELISTED
The Shyft Group
SHYF
$228K 0.03%
10,000
– –
BCYC
88
Bicycle Therapeutics
BCYC
$276M
$223K 0.03%
10,500
– –
IBRX icon
89
ImmunityBio
IBRX
$7.32B
$204K 0.03%
112,000
+89,000
+387% +$277K
RLAY icon
90
Relay Therapeutics
RLAY
$4.06B
$165K 0.02%
10,000
– –
PMVP icon
91
PMV Pharmaceuticals
PMVP
$62.9M
$119K 0.02%
25,000
+5,000
+25% +$35.2K
GOEV
92
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$66.9K 0.01%
223
– –
TNGX icon
93
Tango Therapeutics
TNGX
$4.35B
$39.5K 0.01%
10,000
– –
BN icon
94
Brookfield
BN
$103B
– –
-11,343
Closed -$238K
GS icon
95
Goldman Sachs
GS
$309B
– –
-670
Closed -$230K
MRTX
96
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-5,000
Closed -$227K
1 2 3
4

Similar funds

SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
PTC
Private Trust Company Cleveland, Ohio $1.12B AUM 21.35% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
EC
Estate Counselors Thiensville, Wisconsin $1.12B AUM 20.13% 1-Year Est. Return
AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return

Jay A. Fishman Ltd's Q1 2023 Portfolio in Review

As of Q1 2023, Jay A. Fishman Ltd held 96 positions worth $783M, up 10% from $711M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 3.1%. Jay A. Fishman Ltd opened no new positions and exited 3, leaving the 96-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.

  • Jay A. Fishman Ltd added most to Zoetis in Q1 2023, an estimated $7.32M increase.
  • Jay A. Fishman Ltd's biggest Q1 2023 reduction was Bristol-Myers Squibb, cutting an estimated $5.3M.
  • Jay A. Fishman Ltd fully exited Brookfield in Q1 2023, selling an estimated $238K.
  • Jay A. Fishman Ltd's ten largest holdings make up 67% of its $783M portfolio in Q1 2023.
  • Jay A. Fishman Ltd opened 0 new positions and closed 3 in Q1 2023.
  • Jay A. Fishman Ltd's portfolio value rose 10% quarter-over-quarter to $783M.

Based on Jay A. Fishman Ltd's 13F filing for Q1 2023, filed 9 May 2023.